WVEWave Life Sciences Ltd
WVE
Wave Life Sciences Ltd3,333
Mkt Cap
$2.66BVolume
81.0052W High
$21.7352W Low
$5.28PE Ratio
-19.45WVE Fundamentals
Price
$15.36Prev Close
$14.54Open
$14.5850D MA
$14.57Beta
1.34Avg. Volume
4.7MEPS (Annual)
-$0.7015P/B
18.71Rev/Employee
$376,048.61$1,441.69
Earnings Recap
• Reported GAAP EPS of -$0.30 down -266.67% YoY • Reported revenue of $17.24M down -79.41% YoY • Wave Life Sciences Ltd expects its cash and cash equivalents of $602.1M as of December 31, 2025, to fund operations into the third quarter of 2028.
Bullish
Wave Life Sciences Ltd maintains a strong cash position of $602.1M, funding operations into Q3 2028. The company is advancing WVE-007 for obesity and progressing its RNA editing portfolio with WVE-006 and WVE-008.
Bearish
Wave Life Sciences Ltd experienced a significant revenue decrease to $17.2M and a net loss of $53.2M in Q4 2025, alongside increased operating expenses and reliance on external milestone payments.